| Document Date: 2013-09-20 15:13:51
Open Document File Size: 443,02 KBShare Result on Facebook
Company SPRINT / Merck / Merck Sharp & Dohme Corp. / Merck & Co. Inc. / / Event Reorganization / FDA Phase / / Facility Laboratory Values Changes / Laboratory Tests / Laboratory Tests ADVERSE REACTIONS / / IndustryTerm oral contraceptive product / food / / MedicalCondition HIV / Gastrointestinal Disorders General Disorders / headache / HBV / myopathy / skin and subcutaneous tissue disorders alopecia / pulmonary arterial hypertension / Serious acute hypersensitivity / cerebrovascular accident / nausea / Gastrointestinal Disorders Dysgeusia / cirrhosis / compensated liver disease / hepatitis C / Stevens-Johnson syndrome / syncope / fatigue / acute hypersensitivity / pulmonary embolism / Diarrhea / Hypersensitivity / previously untreated CHC / infections / birth defects / hypotension / acute myocardial infarction / hyperkalemia / Insomnia / disease / Chills / dysgeusia / Carcinogenesis / erectile dysfunction / cardiac arrhythmias / Neutropenia / HCV / exfoliative dermatitis / rhabdomyolysis / vomiting / deep vein thrombosis / compensated cirrhosis / urticaria / angioedema / fetal death / respiratory depression / infection / dizziness / dyspnea / exertional dyspnea / Rash / HCV-RNA / Anemia / chronic hepatitis C / syndrome / eosinophilia / / MedicalTreatment Oral Contraceptives / contraception / organ transplant / / Organization DOSAGE AND ADMINISTRATION / FDA / / Person Patients Without Cirrhosis / / / Position investigator / General / / Product SPRINT / simvastatin / Carbamazepine / PegIntron / Triazolam / Peginterferon / Rifampin / REVATIO / phenytoin / diflunisal / ibuprofen / digoxin / Ribavirin / REBETOL / Lovastatin / VICTRELIS / / Technology Alpha / ESA / Transplantation / Pharmacokinetics / Pharmacodynamics / genotype / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION